💨 Abstract

Emily Kramer-Golinkoff, a 40-year-old woman with advanced cystic fibrosis caused by a rare genetic mutation, struggles daily with simple tasks due to market forces that prioritize treatments for more common genetic mutations. While gene therapies are being developed, they are not yet available and may not work for individuals with Kramer-Golinkoff's specific mutation.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖